13-24316111-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_178540.5(C1QTNF9):āc.108C>Gā(p.His36Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000614 in 1,612,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000059 ( 0 hom., cov: 30)
Exomes š: 0.000062 ( 0 hom. )
Consequence
C1QTNF9
NM_178540.5 missense
NM_178540.5 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 2.15
Genes affected
C1QTNF9 (HGNC:28732): (C1q and TNF related 9) Enables identical protein binding activity. Predicted to be involved in signal transduction. Predicted to be located in extracellular region. Predicted to be part of collagen trimer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.40370023).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C1QTNF9 | NM_178540.5 | c.108C>G | p.His36Gln | missense_variant | 2/4 | ENST00000332018.5 | |
C1QTNF9 | NM_001303137.2 | c.108C>G | p.His36Gln | missense_variant | 3/5 | ||
C1QTNF9 | NM_001303138.2 | c.108C>G | p.His36Gln | missense_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C1QTNF9 | ENST00000332018.5 | c.108C>G | p.His36Gln | missense_variant | 2/4 | 1 | NM_178540.5 | P1 | |
C1QTNF9-AS1 | ENST00000449656.1 | n.84G>C | non_coding_transcript_exon_variant | 2/2 | 5 | ||||
C1QTNF9 | ENST00000382071.6 | c.108C>G | p.His36Gln | missense_variant | 2/4 | 5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000595 AC: 9AN: 151348Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
9
AN:
151348
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251234Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135770
GnomAD3 exomes
AF:
AC:
7
AN:
251234
Hom.:
AF XY:
AC XY:
5
AN XY:
135770
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000616 AC: 90AN: 1461490Hom.: 0 Cov.: 32 AF XY: 0.0000646 AC XY: 47AN XY: 727004
GnomAD4 exome
AF:
AC:
90
AN:
1461490
Hom.:
Cov.:
32
AF XY:
AC XY:
47
AN XY:
727004
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000595 AC: 9AN: 151348Hom.: 0 Cov.: 30 AF XY: 0.0000677 AC XY: 5AN XY: 73864
GnomAD4 genome
AF:
AC:
9
AN:
151348
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
73864
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2021 | The c.108C>G (p.H36Q) alteration is located in exon 2 (coding exon 1) of the C1QTNF9 gene. This alteration results from a C to G substitution at nucleotide position 108, causing the histidine (H) at amino acid position 36 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Gain of catalytic residue at P34 (P = 0.0022);Gain of catalytic residue at P34 (P = 0.0022);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at